GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,468.00p
   
  • Change Today:
    -20.50p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,293.50p
  • Currency: UK Pounds
  • Shares Issued: 4,129.58m
  • Volume: 1,369,714
  • Market Cap: £60,622m
  • RiskGrade: 129
  • Beta: 0.01

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
28-Mar-25 JP Morgan Cazenove Underweight 1,488.50p - - Reiteration
07-Jan-25 JP Morgan Cazenove Underweight 1,357.50p - - Reiteration
11-Dec-24 JP Morgan Cazenove Underweight 1,340.50p - - Reiteration
29-Nov-24 Berenberg Bank Buy 1,335.00p 1,820.00p 1,600.00p Reiteration
10-Sep-24 Berenberg Bank Buy 1,671.00p - 1,820.00p Reiteration
03-Sep-24 Deutsche Buy 1,655.00p - 1,850.00p Reiteration
28-Aug-24 Shore Capital Buy 1,651.50p - - Reiteration
16-Aug-24 Shore Capital Buy 1,591.00p - - Reiteration
14-Aug-24 Berenberg Bank Buy 1,597.50p - 1,820.00p Reiteration
31-Jul-24 Deutsche Buy 1,512.00p 1,950.00p 1,850.00p Reiteration
29-Jul-24 JP Morgan Cazenove Underweight 1,557.00p - - Reiteration
05-Jul-24 Citigroup Buy 1,511.00p 2,120.00p 1,900.00p Reiteration
02-Jul-24 JP Morgan Cazenove Underweight 1,503.50p - - Reiteration
28-Jun-24 Deutsche Buy 1,529.50p - 1,950.00p Reiteration
27-Jun-24 Jefferies Buy 1,526.00p - 2,100.00p Reiteration
27-Jun-24 Shore Capital Buy 1,526.00p - - Reiteration
24-Jun-24 Citigroup Buy 1,608.50p - 2,100.00p Reiteration
18-Jun-24 JP Morgan Cazenove Underweight 1,612.00p - - Reiteration
18-Jun-24 Deutsche Buy 1,612.00p - 1,950.00p Reiteration
12-Jun-24 Shore Capital Buy 1,605.00p - - Reiteration
04-Jun-24 JP Morgan Cazenove Underweight 1,615.00p - - Reiteration
07-May-24 Barclays Equal-weight 1,761.00p - 1,725.00p Reiteration
02-May-24 JP Morgan Cazenove Underweight 1,728.50p 1,530.00p 1,660.00p Reiteration
01-May-24 Shore Capital Buy 1,705.00p - - Reiteration
17-Apr-24 Deutsche Buy 1,590.00p - 1,950.00p Reiteration
08-Apr-24 Barclays Equal-weight 1,620.00p - 1,725.00p Reiteration
12-Mar-24 Deutsche Buy 1,685.20p - 1,950.00p Reiteration
07-Mar-24 Shore Capital Buy 1,711.20p - - Reiteration
27-Feb-24 Deutsche Buy 1,671.00p - 1,950.00p Reiteration
15-Feb-24 Shore Capital Buy 1,663.00p - - Reiteration
14-Feb-24 Berenberg Bank Buy 1,668.00p 1,650.00p 1,820.00p Reiteration
09-Feb-24 Barclays Buy 1,660.00p - 1,950.00p Reiteration
31-Jan-24 Shore Capital Buy 1,568.00p - - Reiteration
18-Dec-23 Barclays Equal-weight 1,442.60p - 1,575.00p Reiteration
28-Nov-23 Citigroup Neutral 1,411.80p - - Reiteration
24-Nov-23 Berenberg Bank Buy 1,422.60p - 1,650.00p Reiteration
06-Nov-23 Barclays Equal-weight 1,405.00p - 1,575.00p Reiteration
11-Oct-23 Shore Capital Buy 1,519.20p - - Reiteration
03-Oct-23 Deutsche Buy 1,485.20p - - Reiteration
02-Oct-23 Citigroup Neutral 1,484.00p - - Reiteration
29-Sep-23 JP Morgan Cazenove Underweight 1,492.00p - - Reiteration
08-Sep-23 JP Morgan Cazenove Underweight 1,444.20p - - Reiteration
05-Sep-23 Deutsche Buy 1,381.40p - 1,700.00p Reiteration
04-Sep-23 Barclays Equal-weight 1,373.60p - 1,450.00p Reiteration
28-Jul-23 Berenberg Bank Buy 1,383.00p - 1,730.00p Reiteration
20-Jul-23 JP Morgan Cazenove Underweight 1,387.20p - - Reiteration
26-Jun-23 Citigroup Neutral 1,419.80p - 1,700.00p Reiteration
26-Jun-23 Jefferies Hold 1,419.80p - 1,575.00p Reiteration
16-Jun-23 Shore Capital Buy 1,364.60p - - Reiteration
14-Jun-23 JP Morgan Cazenove Underweight 1,363.40p - 1,400.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency UK Pounds
Share Price 1,468.00p
Change Today -20.50p
% Change -1.38 %
52 Week High 1,812.50p
52 Week Low 1,293.50p
Volume 1,369,714
Shares Issued 4,129.58m
Market Cap £60,622m
Beta 0.01
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.97% below the market average66.97% below the market average66.97% below the market average66.97% below the market average66.97% below the market average
14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average
Price Trend
2.97% above the market average2.97% above the market average2.97% above the market average2.97% above the market average2.97% above the market average
30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average
Income
62.82% above the market average62.82% above the market average62.82% above the market average62.82% above the market average62.82% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
47.2% below the market average47.2% below the market average47.2% below the market average47.2% below the market average47.2% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 15
Sell 3
Strong Sell 0
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 20-Feb-25 14-Nov-24
Paid 10-Apr-25 09-Jan-25
Amount 16.00p 15.00p

Trades for 31-Mar-2025

Time Volume / Share Price
12:11 13 @ 1,468.17p
12:11 572 @ 1,468.00p
12:11 448 @ 1,468.00p
12:11 14 @ 1,468.00p
12:10 1,031 @ 1,468.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page